Unipharma.ch

FDA Approves Ofatumumab (Arzerra) for Patients With CLL Refractory to Fludarabine and Alemtuzumab

RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid ArthritisFirst-in-class therapy represents a novel approach to treat patients with moderate to severe rheumatoid arthritis.

LITAK^® is approved for recurrent or refractory follicular and diffuse non-Hodgkin's lymphoma, recurrent or refractory chronic lymphocytic leukemia and recurrent or refractory lymphoplasmacytic lymphoma (Waldenström's macroglobulinemia) in Switzerland (country of origin) since 2000.

Bayer will start marketing the new oral, once-daily anticoagulant very soon / First-in-class product to demonstrate superior efficacy to current standard of care

A partire dal 01 novembre 2008 Unipharma SA distribuirà in esclusiva in Italia il prodotto:

PRILOCAINE HYPERBAR SINTETICA  2%  10 fiale  5 ml

Ele foi ativado o sistema de consulta on-line de drogas que Unipharma ofertas no mercado. Você pode solicitar a activação de uma conta de acesso à área restrita.

Unipharma confirma a sua participação na próxima conrgesso SIFO a ser realizada em Nápoles de 12 a 15 de Outubro de 2008.

GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine], the first combination vaccine to offer protection against diphtheria, tetanus, pertussis and polio diseases in one shot.